ScholarIQanswers from OpenAlex
Central Dermatology
InstitutionResearch output, impact & collaborations
Central Dermatology is a institution indexed in ScholarIQ from OpenAlex.
What is known about Central Dermatology?
ScholarIQrecord summary
Central Dermatology is a research organisation in St Louis, US. OpenAlex records 807 works and 34,861 citations for it. 125 researchers list it as their most recent affiliation.
How many works does Central Dermatology have?
ScholarIQindexed works
Central Dermatology has 807 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Central Dermatology have?
ScholarIQcitation count
Central Dermatology has 34,861 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Central Dermatology?
ScholarIQresearcher count
Central Dermatology has 125 researchers in the ScholarIQ index.
What is the average h-index at Central Dermatology?
ScholarIQavg h-index
Central Dermatology has an average h-index of 59 in OpenAlex.
What is the ROR of Central Dermatology?
ScholarIQror
The ROR for Central Dermatology is on the source record.
What is the OpenAlex record for Central Dermatology?
ScholarIQopenalex
The OpenAlex for Central Dermatology is on the source record.
Who are the most-cited researchers behind Central Dermatology?
ScholarIQtop researchers by citations
What are the most-cited papers on Central Dermatology?
ScholarIQmost cited works
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Craig L. Leonardi, Alexa B. Kimball, Kim Papp, Newman Yeilding, Cynthia Guzzo, Yuhua Wang, Shu Li, Lisa T. Dooley, Kenneth B. Gordon
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
Alan Menter, Bruce Strober, Daniel H. Kaplan, Darío Kivelevitch, Elizabeth Farley Prater, Benjamin K. Stoff, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn Marie R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Arthur Kavanaugh, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Reena Rupani, Michael Siegel, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Craig A. Elmets
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Alan Menter, Stephen K. Tyring, Kenneth B. Gordon, Alexa B. Kimball, Craig L. Leonardi, Richard G. Langley, Bruce Strober, Martin Kaul, Yihua Gu, Martin M. Okun, Kim Papp
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Kenneth B. Gordon, Andrew Blauvelt, Kim Papp, Richard G. Langley, Thomas A. Luger, Mamitaro Ohtsuki, Kristian Reich, David A. Amato, Susan Ball, Daniel Braun, Gregory S. Cameron, J. Erickson, Robert J. Konrad, Talia M. Muram, Brian J. Nickoloff, Olawale Osuntokun, Roberta J. Secrest, Fangyi Zhao, Lotus Mallbris, Craig L. Leonardi
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities
Craig A. Elmets, Craig L. Leonardi, Dawn Marie R. Davis, Joel M. Gelfand, Jason Lichten, Nehal N. Mehta, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Boni E. Elewski, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Darío Kivelevitch, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Henry W. Lim, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Elizabeth Farley Prater, Reena Rupani, Michael Siegel, Benjamin K. Stoff, Bruce Strober, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Alan Menter
How much of the research on Central Dermatology is open access?
ScholarIQopen access share
33%OPEN ACCESS